These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 32038957)
1. Extent and characteristics of immune infiltration in clear cell renal cell carcinoma and the prognostic value. Wang Y; Yang J; Zhang Q; Xia J; Wang Z Transl Androl Urol; 2019 Dec; 8(6):609-618. PubMed ID: 32038957 [TBL] [Abstract][Full Text] [Related]
2. SAA1 Has Potential as a Prognostic Biomarker Correlated with Cell Proliferation, Migration, and an Indicator for Immune Infiltration of Tumor Microenvironment in Clear Cell Renal Cell Carcinoma. Xu Z; Wu Y; Fu G; Chen X; Sun J; Tian J; Jiang P; Wang Y; Jin B Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108666 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of alternative polyadenylation regulators of CTLA4 and immune infiltration in clear cell renal cell carcinoma. Zhou M; Long W; Xiong M; Zhang F; Chen L; Chen J; Pang Z; Hou T; Li W Transl Androl Urol; 2023 Apr; 12(4):533-548. PubMed ID: 37181233 [TBL] [Abstract][Full Text] [Related]
4. Identification and validation of novel prognostic markers in Renal Cell Carcinoma. Rabjerg M Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890 [TBL] [Abstract][Full Text] [Related]
5. Analysis of Ferroptosis-Related LncRNAs Signatures Associated with Tumor Immune Infiltration and Experimental Validation in Clear Cell Renal Cell Carcinoma. Chen X; Tu J; Ma L; Huang Y; Yang C; Yuan X Int J Gen Med; 2022; 15():3215-3235. PubMed ID: 35342303 [TBL] [Abstract][Full Text] [Related]
6. Identification of a Novel Immune-Related Prognostic Biomarker and Small-Molecule Drugs in Clear Cell Renal Cell Carcinoma (ccRCC) by a Merged Microarray-Acquired Dataset and TCGA Database. Xiao GF; Yan X; Chen Z; Zhang RJ; Liu TZ; Hu WL Front Genet; 2020; 11():810. PubMed ID: 33014010 [TBL] [Abstract][Full Text] [Related]
7. The immune infiltration in clear cell Renal Cell Carcinoma and their clinical implications: A study based on TCGA and GEO databases. Pan Q; Wang L; Chai S; Zhang H; Li B J Cancer; 2020; 11(11):3207-3215. PubMed ID: 32231726 [TBL] [Abstract][Full Text] [Related]
8. ACE2 Correlated With Immune Infiltration Serves As A Novel Prognostic Biomarker In Clear Cell Renal Cell Carcinoma: Implication For COVID-19. Yang W; Li L; Zhang K; Ma K; Xie H; Gong Y; Zhou J; Gong K Int J Biol Sci; 2021; 17(1):20-31. PubMed ID: 33390830 [TBL] [Abstract][Full Text] [Related]
9. Exploration of the relationships between tumor mutation burden with immune infiltrates in clear cell renal cell carcinoma. Zhang C; Li Z; Qi F; Hu X; Luo J Ann Transl Med; 2019 Nov; 7(22):648. PubMed ID: 31930049 [TBL] [Abstract][Full Text] [Related]
10. Systematic analyses of the role of prognostic and immunological EIF3A, a reader protein, in clear cell renal cell carcinoma. Zhang Y; Hua X; Shi H; Zhang L; Xiao H; Liang C Cancer Cell Int; 2021 Dec; 21(1):680. PubMed ID: 34923969 [TBL] [Abstract][Full Text] [Related]
11. Caspase 4 Overexpression as a Prognostic Marker in Clear Cell Renal Cell Carcinoma: A Study Based on the Cancer Genome Atlas Data Mining. Meng L; Tian Z; Long X; Diao T; Hu M; Wang M; Zhang W; Zhang Y; Wang J; He Y Front Genet; 2020; 11():600248. PubMed ID: 33584797 [TBL] [Abstract][Full Text] [Related]
12. Low expression of ferritinophagy-related NCOA4 gene in relation to unfavorable outcome and defective immune cells infiltration in clear cell renal carcinoma. Mou Y; Wu J; Zhang Y; Abdihamid O; Duan C; Li B BMC Cancer; 2021 Jan; 21(1):18. PubMed ID: 33402128 [TBL] [Abstract][Full Text] [Related]
13. Development and Validation of a Clinical Prognostic Model Based on Immune-Related Genes Expressed in Clear Cell Renal Cell Carcinoma. Ren S; Wang W; Shen H; Zhang C; Hao H; Sun M; Wang Y; Zhang X; Lu B; Chen C; Wang Z Front Oncol; 2020; 10():1496. PubMed ID: 32983989 [No Abstract] [Full Text] [Related]
14. CD103+ Tissue Resident T-Lymphocytes Accumulate in Lung Metastases and Are Correlated with Poor Prognosis in ccRCC. Sanders C; Hamad ASM; Ng S; Hosni R; Ellinger J; Klümper N; Ritter M; Stephan C; Jung K; Hölzel M; Kristiansen G; Hauser S; Toma MI Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326691 [TBL] [Abstract][Full Text] [Related]
15. The Immune-Related Gene HCST as a Novel Biomarker for the Diagnosis and Prognosis of Clear Cell Renal Cell Carcinoma. Zhou Y; Wang X; Zhang W; Liu H; Liu D; Chen P; Xu D; Liu J; Li Y; Zeng G; Li M; Wu Z; Zhang Y; Wang X; DiSanto ME; Zhang X Front Oncol; 2021; 11():630706. PubMed ID: 33968730 [TBL] [Abstract][Full Text] [Related]
16. Identification of Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma (ccRCC) by Transcriptomics. Zhang S; Xu X; Wang Y; Zhu Y; Wang J; Wang H; Guo J Ann Clin Lab Sci; 2021 Sep; 51(5):597-608. PubMed ID: 34686501 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of Wang T; Xie F; Li YH; Liang B Future Oncol; 2021 Dec; 17(36):5033-5044. PubMed ID: 34704468 [TBL] [Abstract][Full Text] [Related]
18. DDX39 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with clear cell renal cell carcinoma. Bao Y; Jiang A; Dong K; Gan X; Gong W; Wu Z; Liu B; Bao Y; Wang J; Wang L Int J Biol Sci; 2021; 17(12):3158-3172. PubMed ID: 34421357 [TBL] [Abstract][Full Text] [Related]
19. Prognostic biomarker CPEB3 and its associations with immune infiltration in clear cell renal cell carcinoma. Hong H; Shi X; Ou W; Ou P Biomed Rep; 2024 Apr; 20(4):63. PubMed ID: 38476610 [TBL] [Abstract][Full Text] [Related]
20. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma. Fan B; Wang W; Zhang X; Sun M; Wang X; Chen Z; Liu W; Wang Q; Yu N; Li X BMC Cancer; 2019 Jun; 19(1):534. PubMed ID: 31159774 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]